Skip to content

Bladder Thermal Distention for Patients With Refractory Overactive Bladder

Bladder Thermal Distention for Patients With Refractory Overactive Bladder

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01842685
Acronym
OAB
Enrollment
20
Registered
2013-04-30
Start date
2013-04-30
Completion date
2014-04-30
Last updated
2013-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive Bladder

Keywords

Overactive Bladder, Bladder Distention

Brief summary

In this study, the investigators will evaluate the efficacy of Bladder Thermal Distention (BTD) in patients with overactive bladder syndrome who failed previous treatment of anticholinergic drugs. The investigators' hypothesis is that it will improve the storage symptoms.

Detailed description

Inclusion criteria: 1. Patients with overactive bladder syndrome 2. Detrusor Overactivity proven in urodynamic test Exclusion criteria: 1. Mixed urinary incontinence 2. Active urinary tract infection 3. Urethral Stricture Outcome measures: 1. Bladder Diaries 2. Urgency questionnaire

Interventions

Bladder Thermal Distention is an approved procedure in Europe from 2006. The treatment is hydrodistention of the bladder with a warm saline (up to 45C). The procedure lasts 1 hour. The saline is infused constantly through a 3 ways specific catheter (Unithermia 18F) by the PelvixTT system.

Sponsors

Assaf-Harofeh Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with overactive bladder syndrome * Detrusor Overactivity proven in urodynamic test

Exclusion criteria

* Mixed urinary incontinence * Active urinary tract infection * Urethral Stricture

Design outcomes

Primary

MeasureTime frameDescription
Urgency Questionnaireup to 1 yearPatients will complete the validated USIQ questionnaire

Secondary

MeasureTime frameDescription
Daily frequency of micturitions on Bladder Diaryup to 1 yearPatients will complete bladder diaries before and after the procedure. Frequencies of micturitions per day will be documented

Countries

Israel

Contacts

Primary ContactKobi Stav, MD
stavkobi@gmail.com972-8-9778461

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026